No Data
No Data
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
JMP Securities Maintains Cellectis(CLLS.US) With Buy Rating, Maintains Target Price $6
Cellectis Reports 2024 Financial Results and Strategic Advances
Cellectis | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
Cellectis | 20-F: FY2024 Annual Report